Orgenesis (ORGS) Ownership - Who owns Orgenesis?

Industry: @Biotechnology
27 days until earnings call

Profile

Industry
Biotechnology
Address
20271 Goldenrod Lane
Phone
+1 480 659-6404
Employees
167
Web
https://www.orgenesis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
33.05M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
27.83M
Revenue
529K
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

ORGS
Capitalization
33.1M
P/E Ratio
N/A
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
27.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
529K
ROE
N/A
Book Value
-27.72M
P/B Ratio
1.38
Cash Flow
N/A
Earnings
-1.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
0.07
Current Revenue Per Employee
965.75
Dividends Per Share - Security
N/A
EBITDA
-47.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
-248.94
Revenue To Assets
-73.53
Shares Held By Institutions
1.86M
Shares Outstanding - Current
47.2M
Total Liabilities
58.5M
Total Volume MTD
N/A
Value
1
Gain YTD
39.824
View a ticker or compare two or three
ORGS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a development stage company, which focuses on treatment of diabetes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
20271 Goldenrod Lane
Phone
+1 480 659-6404
Employees
167
Web
https://www.orgenesis.com